Actively Recruiting

Phase Not Applicable
Age: 14Years - 70Years
All Genders
NCT05662540

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

Led by Ruijin Hospital · Updated on 2024-10-26

40

Participants Needed

1

Research Sites

174 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study intends to evaluate the application value of Positron Emission Tomography/Magnetic Resonance (PET/MR) in the staging and efficacy evaluation of NK/T cell lymphoma, aiming to explore a more accurate system for predicting the prognosis of patients and guiding the treatment.

CONDITIONS

Official Title

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

Who Can Participate

Age: 14Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pathologically diagnosed NK/T-cell lymphoma based on the WHO classification 2016
  • Age from 14 to 70 years-old
  • ECOG 0-2 score
  • Patients with a life expectancy of at least 6 months
  • Patient has not been treated before for NK/T cell lymphoma
  • Commit to abide by the research procedures and cooperate with the implementation of the whole process of research
  • Written informed consent
Not Eligible

You will not qualify if you...

  • Diagnosed aggressive NK cell leukemia
  • Pregnant or lactating women
  • Liver and kidney insufficiency
  • Implanted functional electronic devices such as cardiac pacemakers
  • Carotid aneurysm clipping and other implants made of ferromagnetic materials
  • Implanted perfusion devices such as insulin perfusion pumps
  • Patients who do not cooperate in examinations due to coma, mental illness, or critical illness
  • Claustrophobia
  • Other concurrent and uncontrolled medical conditions that may affect participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ruijin Hospital

Shanghai, Shanghai Municipality, China, 200020

Actively Recruiting

Loading map...

Research Team

W

Weili Zhao

CONTACT

P

Pengpeng Xu

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here